ODP606 Long-term Efficacy of Setmelanotide in Patients With Bardet-Biedl Syndrome

OBJECTIVE: Bardet-Biedl syndrome (BBS) is a rare genetic disease characterized by hyperphagia (pathologic insatiable hunger) and early-onset, severe obesity believed to be driven by impaired signaling in the melanocortin-4 receptor (MC4R) pathway. In a Phase 2 and a pivotal Phase 3 trial, treatment...

Descripción completa

Detalles Bibliográficos
Autores principales: Argente, Jesús, Beales, Philip, Clément, Karine, Dollfus, Hélène, Forsythe, Elizabeth, Haqq, Andrea, Haws, Robert, Martos-Moreno, Gabriel, Mittleman, Robert, Yanovski, Jack, Yuan, Guojun, Chung, Wendy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Adipose Tissue, Appetite, & Obesity
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624643/
http://dx.doi.org/10.1210/jendso/bvac150.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9624643/
http://dx.doi.org/10.1210/jendso/bvac150.029

Ejemplares similares